MIRRIAM MATULULA: Open Payments
NPI 1306591367 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 7 payments from 4 companies in 2025. Trend: 2023 $100 · 2024 $361 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $192 |
| Viatris Specialty LLC | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $120 |
| Alkermes, Inc. | 1 | $102 |
Products named: AUSTEDO XR, YUPELRI, INGREZZA, LYBALVI.
Industry payments across PA — which companies pay providers there.
